Metraipolis › archive › dc_e5ebb4091c25

The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trial — Europe PMC PMID:41324008

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41324008
DOI: 10.1016/j.eclinm.2025.103648
License (as archived): solo-consultazione
Archived: 2026-11-08T13:37:03.533Z
SHA-256 of the archived text: 07c2061360d105f97b2a2afc67b47a823609c5370e3ab32e86a9e0e9f0a75dd9
Stable URL of this page: https://metraipolis.com/documento/dc_e5ebb4091c25

How to cite

The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trial — Europe PMC PMID:41324008 — Europe PMC (en), https://europepmc.org/article/MED/41324008 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e5ebb4091c25 (Metraipolis archive dc_e5ebb4091c25, sha256 07c2061360d105f97b2a2afc67b47a823609c5370e3ab32e86a9e0e9f0a75dd9)

BibTeX

@misc{dce5ebb4091c25,
  title = {The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trial — Europe PMC PMID:41324008},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41324008},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e5ebb4091c25; sha256 07c2061360d105f97b2a2afc67b47a823609c5370e3ab32e86a9e0e9f0a75dd9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41324008. Agents can read the archived copy with the MCP tool read_document.